Locations:
Search IconSearch

Neurosciences

Neurosurgeon

Benzel Symposium Launched AANS Meeting with Reflections on Spine Care — and an Eye to the Future

Neurosurgery luminaries share a generation’s worth of experience and wisdom

19-NEU-321-excessive-sleepiness-650×450

Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial

New drug for adults with OSA or narcolepsy expected to launch soon

19-NEU-320-RNS-neurostimulation-650×450

Seizure Reductions with Responsive Neurostimulation Grow Over Time, Long-Term Study Shows

75% median reduction in seizures observed over 9 years of treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-322-immunosuppression-650×450
May 7, 2019/Cancer

Degree of Immunosuppression Predicts Glioblastoma Prognosis, Temozolomide Studies Suggest

Experience to date highlights need for immunotherapy focus

19-NEU-325-deep-gray-matter_650x450

Assessing Deep Gray Matter Atrophy as a Predictor of Clinical Disability in MS

Study finds strong association between brain/thalamic volume and T2 lesion volume

19-NEU-326-multiple-sclerosis-650×450

Highly Effective Therapies Used in Only a Minority of Relapsing MS Cases, Study Finds

Prescribing practices analyzed over 12+ years across 10 sites

19-NEU-324-SPRINT-MS-650×450

SPRINT-MS Subanalysis Shows Greater Effect for Ibudilast in Primary Vs. Secondary Progressive MS

Findings may be due to faster atrophy progression in primary progressive MS

19-NEU-323_Parkinsons-Brain-650×450

SYN120 Fails to Show Efficacy Against Parkinson Dementia in Phase 2a SYNAPSE Trial

Disappointing performance for the dual serotonin receptor antagonist

650×450-Wang-NIH-grant

MR Fingerprinting in Epilepsy Garners $3 Million NIH Grant

Pairing of novel imaging technique with post-processing analyses could ultimately reshape care

BackPage 65 of 88Next

Advertisement

Ad